Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$11.18 - $18.6 $105,706 - $175,863
-9,455 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$12.09 - $20.46 $64,403 - $108,990
5,327 Added 129.05%
9,455 $118,000
Q2 2019

Aug 12, 2019

BUY
$18.5 - $25.47 $49,894 - $68,692
2,697 Added 188.47%
4,128 $82,000
Q1 2019

Apr 29, 2019

BUY
$14.62 - $22.13 $10,877 - $16,464
744 Added 108.3%
1,431 $30,000
Q4 2018

Jan 28, 2019

BUY
$17.09 - $38.25 $11,740 - $26,277
687 New
687 $14,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $319M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.